Cancer

INDICATION: B cell lymphoma

Cell and mouse studies suggest promoting PMAIP1 expression or inhibiting MCL1 could enhance the efficacy of BCL-2 inhibitors to treat diffuse large

Read the full 252 word article

User Sign In